Amgen can close Horizon deal by September if no ruling from courts on FTC suit

Amgen and Horizon’s $28 billion merger will close on Sept. 15 if the Federal Trade Commission’s lawsuit to block the merger hasn’t been resolved by that time, the biotech giant said in a securities filing Thursday.

Until then, the deal will be blocked from consummation by…